Interdisciplinary Laboratory of Clinical Analysis (Interlab-UMU), Veterinary School, Campus of Excellence Mare Nostrum, University of Murcia, 30100, Murcia, Espinardo, Spain.
Clinic for Internal Diseases, Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 1000, Zagreb, Croatia.
BMC Vet Res. 2023 Feb 3;19(1):33. doi: 10.1186/s12917-023-03586-4.
Hypothyroidism is the most common endocrine disorder diagnosed in dogs, leading to deleterious effects on a dog's life quality. This study aims to evaluate changes in the redox status in canine hypothyroidism. For this purpose, a comprehensive panel of antioxidants and oxidants biomarkers were measured in serum and saliva of 23 dogs with hypothyroidism, 21 dogs with non-thyroidal illness, and 16 healthy dogs. Among the antioxidants, cupric reducing antioxidant capacity (CUPRAC), ferric reducing ability of plasma (FRAP), Trolox equivalent antioxidant capacity (TEAC), thiol, paraoxonase type 1 (PON-1) and glutathione peroxidase (GPx) were determined in serum and CUPRAC, ferric reducing ability of saliva (FRAS) and TEAC in saliva. The oxidant biomarkers included were total oxidant status (TOS), peroxide-activity (POX-Act), reactive oxygen-derived compounds (d-ROMs), advanced oxidation protein products (AOPP), and thiobarbituric acid reactive substances (TBARS) in serum and AOPP and TBARS in saliva.
Results showed a significantly higher TEAC, PON-1, GPx, TOS, POX-Act, and d-ROMs, and a significantly lower AOPP in serum of dogs with hypothyroidism. Meanwhile, significantly lower FRAS and AOPP were observed in saliva of dogs with hypothyroidism. Once salivary concentrations were corrected based on their total protein concentrations, the only analyte showing significant changes was TBARS which was significantly higher in dogs with hypothyroidism.
Our results show that dogs with hypothyroidism present alterations in the redox status in both serum and saliva. This study should be considered a preliminary study and further research addressing these changes should be made using larger populations.
甲状腺功能减退症是犬最常见的内分泌疾病,会对犬的生活质量产生有害影响。本研究旨在评估犬甲状腺功能减退症的氧化还原状态变化。为此,在 23 只患有甲状腺功能减退症的犬、21 只患有非甲状腺疾病的犬和 16 只健康犬的血清和唾液中测量了一组全面的抗氧化剂和氧化剂生物标志物。在抗氧化剂方面,测定了血清中的铜还原抗氧化能力(CUPRAC)、血浆铁还原能力(FRAP)、Trolox 等效抗氧化能力(TEAC)、巯基、对氧磷酶 1 型(PON-1)和谷胱甘肽过氧化物酶(GPx),以及唾液中的 CUPRAC、唾液铁还原能力(FRAS)和 TEAC。氧化生物标志物包括总氧化状态(TOS)、过氧化物活性(POX-Act)、活性氧衍生化合物(d-ROMs)、氧化蛋白产物(AOPP)和硫代巴比妥酸反应物质(TBARS)在血清中以及唾液中的 AOPP 和 TBARS。
结果表明,甲状腺功能减退症犬的血清 TEAC、PON-1、GPx、TOS、POX-Act 和 d-ROMs 显著升高,AOPP 显著降低。同时,甲状腺功能减退症犬的唾液 FRAS 和 AOPP 显著降低。一旦根据总蛋白浓度校正唾液浓度,唯一显示显著变化的分析物是 TBARS,甲状腺功能减退症犬的 TBARS 显著升高。
我们的研究结果表明,甲状腺功能减退症犬的血清和唾液氧化还原状态均发生改变。本研究应被视为初步研究,应使用更大的人群进一步研究这些变化。